David L. Marchetti - Concepedia

Author

David L. Marchetti

Roswell Park Comprehensive Cancer Center

Also Known As

David L. Marchetti, David Marchetti

Publications

405

Citations

H-Index

Concepts

All Affiliations

Roswell Park Comprehensive Cancer Center University at Buffalo, State University of New York Gynecologic Oncology Group

About

David L. Marchetti is an author at Roswell Park Comprehensive Cancer Center specializing in medicine, oncology, and obstetrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	261
2	Obstetrics	9	9	261
3	Pathology	3	3	72
4	Health Sciences	1	1	31
5	Public Health	1	1	34

David L. Marchetti

Publications

358

Citations

H-Index

Page 1

	Year	Citations
Effect of adjuvant chemotherapy on time to recurrence and survival of stage I uterine sarcomas M. Steven Piver, Shashikant Lele, David L. Marchetti, Journal of Surgical Oncology	1988	53
Treatment of Advanced Ovarian Carcinoma in the Elderly David L. Marchetti, Shashikant B. Lele, Roger L. Priore, Gynecologic Oncology Geriatric OncologyMedicineCancer ManagementGynecologyAdvanced Ovarian Carcinoma	1993	50
Correlation between Extreme Drug Resistance Assay and Response to Primary Paclitaxel and Cisplatin in Patients with Epithelial Ovarian Cancer Gamal H. Eltabbakh, M.Steven Piver, Ronald E. Hempling, Gynecologic Oncology Epithelial Ovarian CancerMedicinePrimary PaclitaxelPharmacologyMetronomic Therapy	1998	46
Radical Hysterectomy and Pelvic Lymphadenectomy Versus Radiation Therapy for Small (≤3 cm) Stage IB Cervical Carcinoma M. Steven Piver, David L. Marchetti, Thomas Patton, American Journal of Clinical Oncology	1988	44
Doxorubicin hydrochloride (adriamycin) cardiotoxicity evaluated by sequential radionuclide angiocardiography M. Steven Piver, David L. Marchetti, K. L. Parthasarathy, Cancer Heart FailureInitial CefGynecologyPharmacotherapyDoxorubicin Hydrochloride	1985	34
Clinical and Pathological Predictive Factors in Women with Adult-type Granulosa Cell Tumor of the Ovary Jeannine Villella, François R. Herrmann, Sadhana Kaul, International Journal of Gynecological Pathology GynecologyPathologyTumor RegistryGynecology OncologyTumor Biology	2007	31
Somatic D-loop mitochondrial DNA mutations are frequent in uterine serous carcinoma Tanja Pejović, Daniela P. Ladner, Marilyn Intengan, European Journal of Cancer Uterine Serous CarcinomaSomatic VariantMedicineGynecologyPathology	2004	29
Response of combination platinum and gemcitabine chemotherapy for recurrent epithelial ovarian carcinoma Jeannine Villella, David L. Marchetti, Kunle Odunsi, Gynecologic Oncology Combination PlatinumMedicineMetronomic TherapyGynecologyGemcitabine Chemotherapy	2004	20
Pelvic radiation in stage I endometrial adenocarcinoma with high-risk attributes David L. Marchetti, H Caglar, Deborah L. Driscoll, Gynecologic Oncology Gynecological SurgeryRadiation TherapyPelvic RadiationMedicineGynecology	1990	20
Adjuvant cisplatin-based chemotherapy for stage I ovarian adenocarcinoma: A preliminary report M. Steven Piver, John H. Malfetano, Trudy R. Baker, Gynecologic Oncology Adjuvant Cisplatin-based ChemotherapyOvarian AdenocarcinomaMedicinePreliminary ReportGynecology	1989	19

Page 1